The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make ...

Iowa pharmacists and advocates said Wednesday lawmakers need to pass legislation regulating pharmacy benefit managers, in ...

Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

Cancel anytime. The three biggest pharmacy benefit managers marked up "lifesaving" medications to generate $7.3 billion in ...